SE
60
-3
FOX
51
-6
PLD
45
-5
NOV
52
-5
ORLY
60
-5
NI
72
4
EA
60
-5
TRIP
50
-4
SHW
62
-6
DAL
84
-3
LEN
50
-2
M
31
-3
T
48
3
COF
62
3
TGT
45
-4
VRTX
47
-6
VNO
46
-13
CPB
22
-5
MDLZ
32
-4
FRT
41
-2
SE
60
-3
FOX
51
-6
PLD
45
-5
NOV
52
-5
ORLY
60
-5
NI
72
4
EA
60
-5
TRIP
50
-4
SHW
62
-6
DAL
84
-3
LEN
50
-2
M
31
-3
T
48
3
COF
62
3
TGT
45
-4
VRTX
47
-6
VNO
46
-13
CPB
22
-5
MDLZ
32
-4
FRT
41
-2
Financhill
Back

Credit Suisse Asset Mgmt Income Fund Vs. Avidity Biosciences Industry Stock Comparison

Sell
28

CIK
Credit Suisse Asset Mgmt Income Fund

Last Price:
2.98
Seasonality Move:
2.31%
Sell
28

RNA
Avidity Biosciences

Last Price:
42.16
Seasonality Move:
39.98%
Sell
28
Credit Suisse Asset Mgmt Income Fund (CIK) is a Sell

Is Credit Suisse Asset Mgmt Income Fund a Buy, Sell or Hold?

  • The current Credit Suisse Asset Mgmt Income Fund [CIK] share price is $2.98. The Score for CIK is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • CIK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy, Sell or Hold?

  • The current Avidity Biosciences [RNA] share price is $42.18. The Score for RNA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CIK Stock Price Chart

What is Credit Suisse Asset Mgmt Income Fund's stock price today?

  • The Credit Suisse Asset Mgmt Income Fund share price today is $2.98
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CIK is experiencing slight buying pressure.

RNA Stock Price Chart

What is Avidity Biosciences's stock price today?

  • The Avidity Biosciences share price today is $42.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing selling pressure, which indicates risk of future bearish movement.

CIK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 44.92 Sell
Chaikin Money Flow: 106488 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.96 - 3.04) Sell
Bollinger Bands (100): (2.99 - 3.09) Sell

RNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.53 Buy
Relative Strength Index (14 RSI): 42.17 Sell
Chaikin Money Flow: -1839481 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.78 - 48.76) Sell
Bollinger Bands (100): (41.56 - 46.96) Sell

CIK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.98 Sell
20-day SMA: 2.99 Sell
50-day SMA: 3.04 Sell
200-day SMA: 3 Sell
8-day EMA: 2.98 Sell
20-day EMA: 2.99 Sell
50-day EMA: 3.02 Sell
200-day EMA: 2.99 Sell

RNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.51 Sell
20-day SMA: 45.87 Sell
50-day SMA: 45.1 Sell
200-day SMA: 34.2 Buy
8-day EMA: 46.84 Sell
20-day EMA: 46.32 Sell
50-day EMA: 45.24 Sell
200-day EMA: 35.58 Buy

Credit Suisse Asset Mgmt Income Fund Earnings Growth & CIK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Avidity Biosciences Earnings Growth & RNA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and a decrease next year of $0.25 per share.

Credit Suisse Asset Mgmt Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Avidity Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):